October 30, 2026
Unveiling a Deceptive Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth unveiling-a-deceptive-alliance-ou-researchers-discover-how-aggressive-breast-cancer-hijacks-immune-cells-to-fuel-growth

Unveiling a Deceptive Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

Neng Nana October 14, 2026
NORMAN, OK – In a significant breakthrough for cancer research, scientists at the University of Oklahoma (OU)...
Read More Read more about Unveiling a Deceptive Alliance: OU Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth
MHRA Unveils Ambitious 2030 Strategy to Revolutionize Drug and Device Regulation Through AI and Patient-Centricity mhra-unveils-ambitious-2030-strategy-to-revolutionize-drug-and-device-regulation-through-ai-and-patient-centricity

MHRA Unveils Ambitious 2030 Strategy to Revolutionize Drug and Device Regulation Through AI and Patient-Centricity

Lina Hope October 14, 2026
London, UK – The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a groundbreaking "2030...
Read More Read more about MHRA Unveils Ambitious 2030 Strategy to Revolutionize Drug and Device Regulation Through AI and Patient-Centricity
Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says and What You Need to Know navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says-and-what-you-need-to-know

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says and What You Need to Know

Dwi Wanna October 14, 2026
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged...
Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says and What You Need to Know
Precision Oncology and the Shift Toward Treatment De-escalation: The CompassHER2-pCR Breakthrough precision-oncology-and-the-shift-toward-treatment-de-escalation-the-compassher2-pcr-breakthrough

Precision Oncology and the Shift Toward Treatment De-escalation: The CompassHER2-pCR Breakthrough

Rifan Muazin October 14, 2026
The landscape of breast cancer treatment is undergoing a fundamental paradigm shift. For decades, the primary objective...
Read More Read more about Precision Oncology and the Shift Toward Treatment De-escalation: The CompassHER2-pCR Breakthrough
Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience strengthening-the-lifeline-who-director-generals-state-visit-to-jordan-highlights-global-health-resilience-1

Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience

Jia Lissa October 14, 2026
AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, concluded a high-stakes two-day...
Read More Read more about Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience

You may have missed

breakthrough-at-salk-institute-unlocking-cellular-energy-with-estrogen-related-receptors

Breakthrough at Salk Institute: Unlocking Cellular Energy with Estrogen-Related Receptors

Nana October 30, 2026
genmab-poised-to-revolutionize-first-line-hnscc-treatment-with-promising-bispecific-antibody-data

Genmab Poised to Revolutionize First-Line HNSCC Treatment with Promising Bispecific Antibody Data

Ammar Sabilarrohman October 30, 2026
from-academic-aspirations-to-a-battle-for-life-international-student-finds-strength-amidst-breast-cancer-diagnosis

From Academic Aspirations to a Battle for Life: International Student Finds Strength Amidst Breast Cancer Diagnosis

Asep Darmawan October 30, 2026
the-architecture-of-hope-how-strategic-philanthropy-and-shop-pink-initiatives-are-fueling-the-next-decade-of-breast-cancer-breakthroughs

The Architecture of Hope: How Strategic Philanthropy and ‘Shop Pink’ Initiatives are Fueling the Next Decade of Breast Cancer Breakthroughs

Layla Zulfa October 30, 2026